2022.a. publikatsioonid

Kokku publikatsioone: 97

Artiklid rahvusvahelistes ajakirjades
1Berger MM., Shenkin A., Schweinlin A., Amrein K., Augsburger M., Biesalski HK., Bischoff SC., Casaer MP., Gundogan K., Lepp HL., de Man AME., Muscogiuri G., Pietka M., Pironi L., Rezzi S., Cuerda C.
ESPEN micronutrient guideline
PUBMED
Clinical Nutrition: 41 (6), 1357-1424, 2022
2Blöndal M., Ainla T., Eha J., Lõiveke P., Marandi T., Saar A., Veldre G., Edfors R., Lewinter C., Jernberg T., Jortveit J., Halvorsen S., Becker D., Csanadi Z., Ferenci T., Andreka P., Janosi A.
Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries
PUBMED
European Heart Journal. Quality of Care & Clinical Outcomes: 8 (3), 307-314, 2022
3Chacon E., Manzour N., Zanagnolo V., Querleu D., Nunez-Cordoba JM., Martin-Calvo N., Capilna ME., Fagotti A., Kucukmetin A., Mom C., ..., Kukk K., SUCCOR study group
Autorite grupp:Leht M., Uppin A.
SUCCOR cone study: conization before radical hysterectomy
PUBMED
International Journal of Gynecological Cancer: 32 (2), 117-124, 2022
4Cimci M., Polad J., Mamas M., Iniguez-Romo A., Chevalier B., Abhaichand R., Aminian A., Roguin A., Maluenda G., Angioi M., Cassel G., Kuramitsu S., Jacobs L., Debrus R., Malik F., Hildick-Smith D., Laanmets P., Roffi M., e-ULTIMASTER investigators
Outcomes and regional differences in practice in a worldwide coronary stent registry
PUBMED
Heart: 108 (16), 1310-1318, 2022
5Cook A., Sharland M., Yau Y., PediBSI Group, Bielicki J.
Autorite grupp:Kõljalg S., Jürna-Ellam M.
Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)
PUBMED
Expert Review of Anti-infective Therapy: 20 (3), 445-456, 2022
6Ding WY., Potpara TS., Blomström-Lundqvist C., Boriani G., Marin F., Fauchier L., Lip GYH., ESC-EHRA EORP-AF Long-Term General Registry Investigators
Autorite grupp:Muda P., Vettus R.
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry
PUBMED
European Journal of Clinical Investigation: 52 (6), Artikkel nr e13745, 2022
7Driemeyer C., Falci DR., Hoenigl M., Cornely OA., Chakrabarti A., Gangneux JP., Segal E., Jürna-Ellam M., Matos T., Meis JF., Perfect JR., Arsenijevic VA., Mares M., Serban DE., Pasqualotto AC.
The current state of Clinical Mycology in Eastern and South-Eastern Europe
PUBMED
Medical Mycology: 60 (4), Artikkel nr myac017, 2022
8Edfors R., Jernberg T., Lewinter C., Blöndal M., Eha J., Lõiveke P., Marandi T., Ainla T., Saar A., Veldre G., Ferenci T., Andreka P., Janosi A., Jortveit J., Halvorsen S.
Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction - novel insights from four national European continuous real-world registries
PUBMED
European Heart Journal. Quality of Care & Clinical Outcomes: 8 (4), 429-436, 2022
9Eger K., Paroczai D., Bacon A., Schleich F., Sergejeva S., Bourdin A., Vachier I., Zervas E., Katsoulis K., Papapetrou D., ...
The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?
PUBMED
ERJ Open Research: 8 (2), Artikkel nr 00065-2022, 2022
10Fuchs CS., Özgüroglu M., Bang YJ., Di Bartolomeo M., Mandala M., Ryu MH., Fornaro L., Olesinski T., Caglevic C., Chung HC., ..., Elme A.
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
PUBMED
Gastric Cancer: 25 (1), 197-206, 2022
11Glikson M., Nielsen JC., Kronborg MB., Michowitz Y., Auricchio A., Barbash IM., Barrabes JA., Boriani G., Braunschweig F., Brignole M., ...
Autorite grupp:Voitk J.
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
PUBMED
Europace: 24 (1), 71-164, 2022
12Grüßer L., Keszei A., Coburn M., Rossaint R., Ziemann S., Kowark A., ETPOS Study Group
Autorite grupp:Karjagin J., Rokk A., Sõrmus A., Rätsep I., Oganjan J., Smirnova N., Kivik P.
Intraoperative transfusion practices and perioperative outcome in the European elderly: A secondary analysis of the observational ETPOS study
PUBMED
PLoS ONE: 17 (1), Artikkel nr e0262110, 2022
13Holmberg CJ., Ny L., Hieken TJ., Block MS., Carr MJ., Sondak VK., Örtenwall C., Katsarelias D., Dimitriou F., Menzies AM., .., Teras J.
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study
PUBMED
European Journal of Cancer: 169, 210-222, 2022
14Jaakonmäki N., Zedde M., Sarkanen T., Martinez-Majander N., Tuohinen S., Sinisalo J., Ryödi E., Autere J., Hedman M., Junttola U., ..., Kõrv L., Kõrv J.
Obesity and the Risk of Cryptogenic Ischemic Stroke in Young Adults
PUBMED
Journal of Stroke and Cerebrovascular Diseases: 31 (5), Artikkel nr 106380, 2022
15Jalasto J., Lassmann-Klee P., Schyllert C., Luukkonen R., Meren M., Larsson M., Põlluste J., Sundblad BM., Lindqvist A., Krokstad S., Kankaanranta H., Kauppi P., Sovijärvi A., Haahtela T., Backman H., Lundbäck B., Piirilä P.
Occupation, socioeconomic status and chronic obstructive respiratory diseases - The EpiLung study in Finland, Estonia and Sweden
PUBMED
Respiratory Medicine: 191, Artikkel nr 106403, 2022
16Kangro K., Kurašin M., Gildemann K., Sankovski E., Žusinaite E., Lello LS., Pert R., Kavak A., Poikalainen V., Lepasalu L., Kuusk M., Pau R., Piiskop S., Rom S., Oltjer R., Tiirik K., Kogermann K., Plaas M., Tiirats T., Aasmäe B., Plaas M., Mumm K., Krinka D., Talpsep E., Kadaja M., Gerhold JM., Planken A., Tover A., Merits A., Männik A., Ustav M. Jr., Ustav M.
Bovine colostrum-derived antibodies against SARS-CoV-2 show great potential to serve as prophylactic agents
PUBMED
PLoS ONE: 17 (6), Artikkel nr e0268806, 2022
17Kobo O., Saada M., Laanmets P., Karageorgiev D., Routledge H., Crowley J., Baello P., Requena JB., Spano F., Perez L., Jimenez Mazuecos JM., Mamas MA., Roguin A.
Impact of peripheral artery disease on prognosis after percutaneous coronary intervention: Outcomes from the multicenter prospective e-ULTIMASTER registry
PUBMED
Atherosclerosis: 344, 71-77, 2022
18Kroese TE., van Hillegersberg R., Schoppmann S., Deseyne PRAJ., Nafteux P., Obermannova R., Nordsmark M., Pfeiffer P., Hawkins MA., Smyth E., ..., Elme A.
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe
PUBMED
European Journal of Cancer: 164, 18-29, 2022
19Lõokene M., Markov N., Nikander M., Neuvonen T., Dilkov D.
Reduction of symptoms in patients with major depressive disorder after transcranial direct current stimulation treatment: A real-world study
Journal of Affective Disorders Reports: 8, Artikkel nr 100347, 2022
20Martin-Loeches I., Timsit JF., Kollef MH., Wunderink RG., Shime N., Novacek M., Kivistik Ü., Rea-Neto A., Bruno CJ., Huntington JA., Lin G., Jensen EH., Motyl M., Yu B., Gates D., Butterton JR., Rhee EG.
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia
PUBMED
Journal of Antimicrobial Chemotherapy: 77 (4), 1166-1177, 2022
21Paz-Ares L., O'Brien MER., Mauer M., Dafni U., Oselin K., Havel L., Gonzalez EE., Isla D., Martinez-Marti A., Faehling M., ...
VP3-2022: Pembrolizumab (pembro) versus placebo for early-stage non-small cell lung cancer (NSCLC) following complete resection and adjuvant chemotherapy (chemo) when indicated: Randomized, triple-blind, phase III EORTC-1416-LCG/ETOP 8-15 e PEARLS/KEYNOTE-091 study
Annals of Oncology: 33 (4), 451-453, 2022
22Pauklin P., Zilmer M., Eha J., Tootsi K., Kals M., Kampus P.
Markers of Inflammation, Oxidative Stress, and Fibrosis in Patients with Atrial Fibrillation
PUBMED
Oxidative Medicine and Cellular Longevity: Artikkel nr 4556671, 2022
23Peebo K., Saluveer E., Küünarpuu H., Orgse T., Harro J.
First-episode psychosis integrative treatment: Estonian experience
PUBMED
Nordic Journal of Psychiatry: 76 (3), 207-214, 2022
24Pikta M., Vasse M., Smock KJ., Moser KA., Van Dievoet MA., Lejniece S., Szanto T., Bautista H., Nouadje G., Banys V.
Establishing reference intervals for von Willebrand factor multimers
PUBMED
Journal of Medical Biochemistry: 41 (1), 115-121, 2022
25Pupina N., Avarlaid A., Sadam H., Pihlak A., Jaago M., Tuvikene J., Rähni A., Planken A., Planken M., Kalso E., Tienari PJ., Nieminen JK., Seppänen MRJ., Vaheri A., Lindholm D., Sinisalo J., Pussinen P., Timmusk T., Palm K.
Immune response to a conserved enteroviral epitope of the major capsid VP1 protein is associated with lower risk of cardiovascular disease
PUBMED
EBioMedicine: 76, Artikkel nr 103835, 2022
26Raukas M., Metsna V., Tammaru M.
Cross-cultural adaptation and validation of the Estonian version of the Oxford Knee Score
PUBMED
Acta Orthopaedica et Traumatologica Turcica: 56 (1), 53-57, 2022
27Rips L., Luik M., Koovit T., Rahu M.
Lower leg muscle recovery takes at least 12 months for functional tests to recover after late reconstruction of the tibialis posterior tendon retinaculum
PUBMED
BMJ Case Reports: 15 (1), Artikkel nr e247273, 2022
28Rubin DT., Dotan I., DuVall A., Bouhnik Y., Radford-Smith G., Higgins PDR., Mishkin DS., Arrisi P., Scalori A., Oh YS., Tole S., Chai A., Chamberlain-James K., Lacey S., McBride J., Panes J., HIBISCUS Study Group
Autorite grupp:Kull K., Borissova J.
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
PUBMED
The Lancet Gastroenterology and Hepatology: 7 (1), 17-27, 2022
29Saar S., Jorgensen J., Lemma AN., Gaarder C., Naess PA., Leppäniemi A., Sallinen V., Pius R., Reinsoo A., Lepp J., Talving P.
Selective non-operative management of penetrating abdominal injuries at Northern European trauma centers: the NordiPen Study
PUBMED
European Journal of Trauma and Emergency Surgery: 48 (3), 2023-2027, 2022
30Schjesvold FH., Dimopoulos MA., Delimpasi S., Robak P., Coriu D., Legiec W., Pour L., Špicka I., Masszi T., Doronin V., ..., OCEAN (OP-103) Investigators
Autorite grupp:Palk K., Kaare A.
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
PUBMED
The Lancet Haematology: 9 (2), e98-e110, 2022
31Szanto T., Zetterberg E., Ramström S., Leinoe EB., Holme PA., Antovic JP., Holmström M., Onundarson PT., Pikta M., Vaide I., Olsson A., Magnusson M., Kärkkäinen S., Bitar M., Poulsen LH., Lassila R., Nordic Haemophilia Council
Platelet function testing: Current practice among clinical centres in Northern Europe
PUBMED
Haemophilia: 28 (4), 642-648, 2022
32Urner M., Barnett AG., Bassi GL., Brodie D., Dalton HJ., Ferguson ND., Heinsar S., Hodgson CL., Peek G., Shekar K., Suen JY., Fraser JF., Fan E., COVID-19 Critical Care Consortium Investigators
Autorite grupp:Beljantsev A., Maasikas O., Rätsep I., Enneveer L., Erikson K.
Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study
PUBMED
BMJ: 377, Artikkel nr e068723, 2022
33Uusküla A., Keis A., Toompere K., Planken A., Rebrov K.
Cluster randomised, controlled, triple-blind trial assessing the efficacy of intranasally administered virus-neutralising bovine colostrum supplement in preventing SARS-CoV-2 infection in household contacts of SARS-CoV-2-positive individuals: a study protocol
PUBMED
Trials: 23 (1), Artikkel nr 92, 2022
34van Veelen A., Elias J., van Dongen IM., Hoebers LPC., Claessen BEPM., Ramunddal T., Laanmets P., Eriksen E., van der Schaaf RJ., Nijveldt R., Henriques JPS., Hirsch A.
Recovery of right ventricular function and strain in patients with ST-segment elevation myocardial infarction and concurrent chronic total occlusion
PUBMED
International Journal of Cardiovascular Imaging: 38 (3), 631-641, 2022
35Örd L., Marandi T., Märk M., Raidjuk L., Kostjuk J., Banys V., Krause K., Pikta M.
Evaluation of DOAC Dipstick Test for Detecting Direct Oral Anticoagulants in Urine Compared with a Clinically Relevant Plasma Threshold Concentration
PUBMED
Clinical and Applied Thrombosis/Hemostasis: 28, Artikkel nr 10760296221084307, 2022
Artiklid "Eesti Arstis"
1Adoberg A., Auerbach A., Telling K., Mihnovitš V., Pertsev I., Kivistik Ü., Seppet J., Riispere Z., Kõlvald K.
Orellaniinimürgistusest põhjustatud neerukahjustus – haigusjuhtude kirjeldus ja kirjanduse ülevaade
Eesti Arst: 101 (1), 43-48, 2022
2Ainla T.
Ideest teostuseni − müokardiinfarktiregistri teekond riikliku registrini 2000−2011
Eesti Arst: 101 (Lisa 1), 3-6, 2022
3Jürgenson A., Sooba E.
Põlve- ja puusaliigese endoproteesimise tõenduspõhise taastusravi korraldus
Eesti Arst: 101 (Lisa 3), 50-54, 2022
4Lepik T., Rätsep I.
Lemierre’i sündroom
Eesti Arst: 101 (5), 315-319, 2022
5Lillo KE.
Amatoksiinimürgistus. Kirjanduse ülevaade ja valge kärbseseene mürgistusega kahe patsiendi haigusjuht
Eesti Arst: 101 (6-7), 374-381, 2022
6Lõiveke P., Saar A.
Kuidas aitab müokardiinfarktiregister leida suurimat tähelepanu vajavaid, suurima suremusriskiga südamelihase infarktiga patsiente?
Eesti Arst: 101 (Lisa 1), 37-42, 2022
7Marandi T., Ainla T.
Müokardiinfarktiregistri tulevikuvisioon
Eesti Arst: 101 (Lisa 1), 50-51, 2022
8Marandi T., Ainla T., Blöndal M., Jürgenson A, Kivistik E., Lukmann A., Lõiveke P., Martinson K., Reinmets J., Saar A., Serg M.
Müokardiinfarktihaige käsitlus esimesel aastal pärast haigestumist
Eesti Arst: 101 (5), 324-328, 2022
9Nurm M.
Taastusravi arendamine Põhja-Eesti Taastusravikeskuses aastatel 1994-2020
Eesti Arst: 101 (Lisa 3), 13-18, 2022
10Orav K.
Epilepsia kirurgiline ravi – alakasutatud võimalus ravimrefraktaarse epilepsia raviks
Eesti Arst: 101 (8), 430-436, 2022
11Ott M., Haavistu L.
Püsiv somatoformne valu
Eesti Arst: 101 (1), 37-42, 2022
12Paal P., Krikmann K., Sikk K., Taba, P., Elmet K., Suija K.
Palliatiivne ravi kui esmatasandi tervishoiuteenus – definitsioon, normid ja tavad
Eesti Arst: 101 (6-7), 349-355, 2022
13Roosipuu A., Vettus E., Vettus R.
Nivolumabist tingitud hulgielundipuudulikkus haigusjuhu näitel
Eesti Arst: 101 (3), 183-187, 2022
14Ross M., Elme A.
Kommentaarid artikli „Trombotsütoos suurendab oluliselt pahaloomulise kasvaja riski” kohta
Eesti Arst: 101 (8), 448-449, 2022
15Saar S., Lipping E., Lepp J., Lepner U., Talving P.
Läbivate kõhuvigastuste selektiivne mitteoperatiivne käsitlus ning praktika Põhja-Euroopa traumakeskustes
Eesti Arst: 101 (4), 225-227, 2022
16Tuulik VR., Jürgenson A., Vaht M.
Luu-lihaskonna kerge ja mõõduka astme ülekoormussündroomide mõjutamine soojus-, vesi- ja mudaraviga: toimemehhanismis ja efektiivsus
Eesti Arst: 101 (Lisa 3), 55-61, 2022
17Vellend O., Gavrilkina J.
Munasarjastruuma. Haigusjuhu kirjeldus koos erialakirjanduse ülevaatega
Eesti Arst: 101 (4), 243-246, 2022
Raamatud, dissertatsioonid
1Erikson K.
The brain as an end organ in sepsis?
Acta Universitatis Ouluensis. D, Medica: 1663, 78, 2022
Konverentsiteesid
1Adamson-Raieste A.
Cancer immunotherapy in early clinical development
Eesti Arst: 101 (Lisa 2), 27, 2022
2del Castillo FJ., Munoz G., Dominguez-Ruiz M., Ciubotariu C., Piris-Villaespesa M., Ley M., Gainza E., Unceta M., Ceberio L., Fdil N., Ross M., Belanger A., Villarrubia J.
NGS-based panel screening of suspected lysosomal disease cases identifies novel pathogenic variants underlying acid sphingomyelinase deficiency (ASMD), Krabbe disease, and lymphatic dysplasia with non-immune hydrops fetalis
Molecular Genetics and Metabolism: 135 (2), S36, 2022
3Federico M., Stepanishyna Y., Skrypets T., Chiattone C., Prince MH., Pavlovsky A., Lymboussakis A., Manni M., Civallero M., de Souza CA., Hawkes EA., Fiad L., Nair R., Kriachok I., Hitz F., Kostina O., Tomuleasa C., Guarini A., Luminari S.
Mature T and NK cell lymphomas classified according to 2016 WHO classification. A report of the international prospective T-cell Project 2.0
Hemasphere: 6 (Suppl 3), 123-124, 2022
4Heinsar S., Bartnikowski N., Hartel G., Seah EP., Colombo SM., Farah SM., Rätsep I., Pauls J., Fraser JF., Suen J.
In vitro evaluation of hemodynamic energy production and circuit loss using four different ECMO arterial cannulae
Artificial Organs: 46 (1), E12-E13, 2022
5Laisaar T., Vanakesa T., Sarana B., Almre I., Saar A.
Nationwide Activity of Lung Cancer Surgery Before and During the COVID-19 Pandemic
IASLC 2022 World Conference on Lung Cancer Abstract Book: 641, 2022
6Luksta M., Ümarik T., Bausys A., Reinsoo A., Rackauskas R., Anglickiene G., Kryzauskas M., Tõnismäe K., Senina V., Seinin D., Bausys R., Strupas K.
The optimal timing for gastrectomy after neoadjuvant chemotherapy
European Journal of Surgical Oncology: 48 (2), e178, 2022
7Mihnovitš V., Põld K., Paasma R.
Cortinarius rubellus poisoning in Estonia: a case series
Clinical Toxicology: 60 (Suppl 1), 32, 2022
8O'Brien MER., Paz-Ares L., Jha N., Dafni U., Oselin K., Havel L., Esteban E., Isla D., Martinez-Marti A., Faehling M., ...
EORTC-1416-LCG/ETOP 8-15 - PEARLS/KEYNOTE-091 study of pembrolizumab versus placebo for completely resected early-stage non-small cell lung cancer (NSCLC): Outcomes in subgroups related to surgery, disease burden, and adjuvant chemotherapy use
Journal of Clinical Oncology: 40 (16 Suppl), Tees nr 8512, 2022
9Peebo K., Saluveer E., Küünarpuu H., Orgse T., Harro J.
First-Episode Psychosis Integrative Treatment: Estonian Experience
Eesti Arst: 101 (Lisa 2), 54, 2022
10Roht L., Hyldebrandt HK., Stormorken AT., Nordgarden H., Sijmons RH., Bos DK., Riegert-Johnson D., Mantia-Macklin S., Muru K., Kahre T., Õunap K.
Phenotype of six families with AXIN2-oligodontia-colorectal cancer syndrome. Cleft palate as a new feature of this syndrome?
European Journal of Human Genetics: 30 (Suppl 1), 372, 2022
11Schwarz G., Bonato S., Lanfranconi S., Matusevicius M., Ghione I., Valcamonica G., Tsivgoulis G., Paiva Nunes A., Mancuso M., Zini A., Candelaresi P., Rand VM., Comi GP., Mazya MV., Ahmed N.
Safety and efficacy of endovascular thrombectomy plus intravenous thrombolysis vs. intravenous thrombolysis alone in mild symptoms strokes with large vessel occlusion: propensity score matched analysis
European Stroke Journal: 7 (1 Suppl), 114, 2022
12Serg M.
New drugs for treating dyslipidemia
Eesti Arst: 101 (Lisa 2), 37, 2022
13Säflund M., Matusevicius M., Egido JA., Ferro JM., Kõrv J., Melis M., Peeters A., Petruzzellis M., Rand VM., Vilionskis A., Mazya MV., Moreira T., Ahmed N.
Initiation of direct oral anticoagulation after reperfusion therapy in ischemic stroke in clinical practice: results from SITS-International Stroke Registry
European Stroke Journal: 7 (1 Suppl), 201, 2022
14Tamm M., Annilo T., Oselin K., Kals M., Keerma K., Kivistik PA., Nurm M., Saare M., Jaal J., Tõnisson N.
Liquid biopsy in lung cancer patients shows advantages compared to FFPE tissue mutational analysis
European Journal of Human Genetics: 30 (Suppl 1), 405-406, 2022
15Valter A.
Current state of art - cancer immunotherapy in clinical practice
Eesti Arst: 101 (Lisa 2), 26, 2022
16Viigimaa M.
Erectile dysfunction in cardiovascular disorders
Journal of Rehabilitation Medicine: 54 (Suppl), 9, 2022
17Villarrubia J., Munoz G., Ciubotariu C., Dominguez-Ruiz M., Piris-Villaespesa M., Unceta M., Ceberio L., Church H., Norouzi M., Ross M., Perez-de Pedro I., Stepien KM., del Castillo FJ.
Adult acid sphingomyelinase deficiency (Niemann-Pick disease type B): A difficult pathway to a diagnosis in 4 novel cases
Molecular Genetics and Metabolism: 135 (2), S125, 2022
Muud publikatsioonid
1Ambos A.
Ameerika Diabeedi Assotsiatsiooni 2022. aasta diabeedi käsitluse standardid
Lege Artis: 1 (6), 53-57, 2022
2Helmdorf M.
Statiinravi alustamine eakatel
Perearst: 7 (181), 22-24, 2022
3Kaarde P.
Hormoonasendusravi võimalikud kasud ja riskid
Lege Artis: 2 (6), 16-18, 2022
4Kaha T.
Patoloogiliste armide korral võib leida abi konservatiivsest ravi
Perearst: 2 (176), 45-48, 2022
5Kaur I.
Kaalukirurgia ja metaboolne kirurgia
Lege Artis: 4 (6), 12-16, 2022
6Kõdar H., Palk K., Ross M.
Ägedad leukeemiad ja nende eduka ravi kaugmõjud
Perearst: 2 (176), 15-18, 2022
7Kütner R, Roht L.
Geneetiliste faktorite roll rinnavähi tekkes
Perearst: 1 (175), 42-44, 2022
8Kütner R.
Rinnatervis on oluline kogu perele
Lege Artis: 5 (6), 3, 2022
9Kütt M.
Tsirkuleerivad ja koelised kasvajamarkerid ning nende kasutamine kliinilises praktikas
Lege Artis: 1 (6), 20-25, 2022
10Lauri V.
Autismispektri häire – mida see endast kujutab, kuidas üles leida eripära ja kuidas sekkuda?
Perearst: 3 (177), 13-16, 2022
11Lotman EM.
Cor pulmonale
Perearst: 4 (178), 56-59, 2022
12Lotman EM.
Haigusjuht: tahhükardia-bradükardia sündroom
Lege Artis: 1 (6), 81-83, 2022
13Lotman EM.
Suukaudsete antitrombootiliste ravimite kasutamine kodade virvendusarütmia ja aterosklerootilise kardiovaskulaarhaiguse ravis
Perearst: 6 (180), 55-58, 2022
14Luman M.
Neerukahjustusega diabeetiku ravivõimalused ja -eelistused
Perearst: 3 (177), 47-53, 2022
15Lõokene M.
Depressioon meestel – mida märgata ja kuidas aidata?
Perearst: 4 (178), 63-66, 2022
16Lõokene M.
Ülevaade transkraniaalsest alalisvoolustimulatsioonist
Perearst: 7 (181), 57-60, 2022
17Mukk P.
GOLD 2022 uuendused pööravad tähelepanu ka COVID-19 pandeemiale
Perearst: 5 (179), 59-64, 2022
18Putnik K.
Melanoomi esinemissagedus kasvab kogu maailmas
Lege Artis: 4 (6), 43-47, 2022
19Roht L.
Rinnavähist geneetiku vaatevinklist
Lege Artis: 5 (6), 8-11, 2022
20Rugo M.
Viljatuse põhjuste kirurgilised ravivõimalused naistel
Lege Artis: 2 (6), 10-12, 2022
21Salus M.
Vitamiin B12 inimese närvisüsteemis
Lege Artis: 4 (6), 68-70, 2022
22Serg M., Tsvetkov E., Sepp A., Viigimaa M.
Düslipideemia müokardi­infarktiga patsientidel – multidistsiplinaarne analüüs
Lege Artis: 5 (6), 45-47, 2022
23Sergejeva S., Melnikova R., Sadam T.
Täiskasvanuea allergilisest astmast perearstile
Perearst: 5 (179), 51-56, 2022
24Viigimaa M.
Oleme unustanud, et rohkem kui pool südame-veresoonkonnahaigustest on ennetatavad
Perearst: 4 (178), 31, 2022
25Viks L.
GOLD-i 2022. aasta ravijuhend: kroonilise obstruktiivse kopsuhaiguse ravisoovitused
Perearst: 1 (175), 59-65, 2022
26Viks L.
Kroonilise obstruktiivse kopsuhaiguse olemusest ja hapnikravist
Lege Artis: 2 (6), 41-46, 2022
27Viks L.
Kroonilise obstruktiivse kopsuhaiguse olemusest ja hapnikravist
Perearst: 6 (180), 37-41, 2022